2025-523079-44-00
CTIS ↗
ASND0047
Turner Syndrome (TS), idiopathic short stature (ISS), short stature homeobox containing gene deficiency (SHOX-D), small for gestational age (SGA)
pharma · Growth Hormone Deficiency, Pediatric
Ascendis Pharma
Ascendis Pharma Endocrinology Division A/S
Ascendis Pharma trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.
Palo Alto, USA HQ
2010 Founded
5 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Palo Alto, USA
- Founded
- 2010
- Employees
- 5
- Programs
- 2
- Drugs
- 7
- Patents
- 6
Ascendis Pharma clinical trials
Registry index of 2 ClinicalTrials.gov studies linked to Ascendis Pharma programs — each row shows trial ID, program name, phase, status, and indication.
Ascendis Pharma trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Ascendis Pharma.